Mortality following hip fracture in men with prostate cancer.

<h4>Background</h4>Hip fractures are associated with increased mortality and are a known adverse effect of androgen deprivation therapy (ADT) for prostate cancer (PCa). It was our aim to evaluate how mortality after hip fracture is modified by PCa and ADT.<h4>Methods</h4>PCa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mieke Van Hemelrijck, Hans Garmo, Karl Michaëlsson, Andreas Thorstenson, Olof Akre, Pär Stattin, Lars Holmberg, Jan Adolfsson
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8eae65d10f5f4d3cbd3292dcc681e174
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8eae65d10f5f4d3cbd3292dcc681e174
record_format dspace
spelling oai:doaj.org-article:8eae65d10f5f4d3cbd3292dcc681e1742021-11-18T08:53:26ZMortality following hip fracture in men with prostate cancer.1932-620310.1371/journal.pone.0074492https://doaj.org/article/8eae65d10f5f4d3cbd3292dcc681e1742013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24086350/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Hip fractures are associated with increased mortality and are a known adverse effect of androgen deprivation therapy (ADT) for prostate cancer (PCa). It was our aim to evaluate how mortality after hip fracture is modified by PCa and ADT.<h4>Methods</h4>PCa dataBase Sweden (PCBaSe 2.0) is based on the National PCa Register and also contains age and county-matched PCa-free men. We selected all men (n = 14,205) who had been hospitalized with a hip fracture between 2006 and 2010; 2,300 men had a prior PCa diagnosis of whom 1,518 (66%) were on ADT prior to date of fracture. Risk of death was estimated with cumulative incidence and standardized mortality ratios (SMRs) to make comparisons with the entire PCa population and the general population.<h4>Results</h4>Cumulative incidences indicated that there was a higher risk of death following a hip fracture for PCa men on ADT than for PCa men not on ADT or PCa-free men, particularly in the first year. The SMRs showed that PCa men on ADT with a hip fracture were 2.44 times more likely to die than the comparison cohort of all PCa men (95%CI: 2.29-2.60). This risk was especially increased during the first month (5.64 (95%CI: 4.16-7.48)). In absolute terms, hip fractures were associated with 20 additional deaths per 1,000 person-years in PCa men not on ADT, but 30 additional deaths per 1,000 person-years for PCa men on ADT, compared to all PCa men.<h4>Conclusion</h4>Hip fractures are associated with higher all-cause mortality in PCa men on ADT than in PCa men not on ADT or PCa-free men, especially within the first three months.Mieke Van HemelrijckHans GarmoKarl MichaëlssonAndreas ThorstensonOlof AkrePär StattinLars HolmbergJan AdolfssonPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e74492 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mieke Van Hemelrijck
Hans Garmo
Karl Michaëlsson
Andreas Thorstenson
Olof Akre
Pär Stattin
Lars Holmberg
Jan Adolfsson
Mortality following hip fracture in men with prostate cancer.
description <h4>Background</h4>Hip fractures are associated with increased mortality and are a known adverse effect of androgen deprivation therapy (ADT) for prostate cancer (PCa). It was our aim to evaluate how mortality after hip fracture is modified by PCa and ADT.<h4>Methods</h4>PCa dataBase Sweden (PCBaSe 2.0) is based on the National PCa Register and also contains age and county-matched PCa-free men. We selected all men (n = 14,205) who had been hospitalized with a hip fracture between 2006 and 2010; 2,300 men had a prior PCa diagnosis of whom 1,518 (66%) were on ADT prior to date of fracture. Risk of death was estimated with cumulative incidence and standardized mortality ratios (SMRs) to make comparisons with the entire PCa population and the general population.<h4>Results</h4>Cumulative incidences indicated that there was a higher risk of death following a hip fracture for PCa men on ADT than for PCa men not on ADT or PCa-free men, particularly in the first year. The SMRs showed that PCa men on ADT with a hip fracture were 2.44 times more likely to die than the comparison cohort of all PCa men (95%CI: 2.29-2.60). This risk was especially increased during the first month (5.64 (95%CI: 4.16-7.48)). In absolute terms, hip fractures were associated with 20 additional deaths per 1,000 person-years in PCa men not on ADT, but 30 additional deaths per 1,000 person-years for PCa men on ADT, compared to all PCa men.<h4>Conclusion</h4>Hip fractures are associated with higher all-cause mortality in PCa men on ADT than in PCa men not on ADT or PCa-free men, especially within the first three months.
format article
author Mieke Van Hemelrijck
Hans Garmo
Karl Michaëlsson
Andreas Thorstenson
Olof Akre
Pär Stattin
Lars Holmberg
Jan Adolfsson
author_facet Mieke Van Hemelrijck
Hans Garmo
Karl Michaëlsson
Andreas Thorstenson
Olof Akre
Pär Stattin
Lars Holmberg
Jan Adolfsson
author_sort Mieke Van Hemelrijck
title Mortality following hip fracture in men with prostate cancer.
title_short Mortality following hip fracture in men with prostate cancer.
title_full Mortality following hip fracture in men with prostate cancer.
title_fullStr Mortality following hip fracture in men with prostate cancer.
title_full_unstemmed Mortality following hip fracture in men with prostate cancer.
title_sort mortality following hip fracture in men with prostate cancer.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/8eae65d10f5f4d3cbd3292dcc681e174
work_keys_str_mv AT miekevanhemelrijck mortalityfollowinghipfractureinmenwithprostatecancer
AT hansgarmo mortalityfollowinghipfractureinmenwithprostatecancer
AT karlmichaelsson mortalityfollowinghipfractureinmenwithprostatecancer
AT andreasthorstenson mortalityfollowinghipfractureinmenwithprostatecancer
AT olofakre mortalityfollowinghipfractureinmenwithprostatecancer
AT parstattin mortalityfollowinghipfractureinmenwithprostatecancer
AT larsholmberg mortalityfollowinghipfractureinmenwithprostatecancer
AT janadolfsson mortalityfollowinghipfractureinmenwithprostatecancer
_version_ 1718421214576246784